| Primary |
| Product Used For Unknown Indication |
36.6% |
| Schizophrenia |
14.8% |
| Drug Use For Unknown Indication |
7.7% |
| Psychotic Disorder |
6.3% |
| Anxiety |
4.9% |
| Bipolar Disorder |
4.9% |
| Schizophrenia, Paranoid Type |
4.2% |
| Depression |
2.8% |
| Mania |
2.8% |
| Schizoaffective Disorder |
2.8% |
| Dementia |
2.1% |
| Psychosis |
2.1% |
| Attention Deficit/hyperactivity Disorder |
1.4% |
| Autism |
1.4% |
| Psychomotor Hyperactivity |
1.4% |
| Abnormal Behaviour |
0.7% |
| Acute Pulmonary Oedema |
0.7% |
| Aggression |
0.7% |
| Alcoholism |
0.7% |
| Alzheimer's Disease |
0.7% |
|
| Toxicity To Various Agents |
8.3% |
| Weight Increased |
8.3% |
| Withdrawal Syndrome |
8.3% |
| Tachycardia |
6.3% |
| Treatment Noncompliance |
6.3% |
| Death |
4.2% |
| Growth Retardation |
4.2% |
| Myasthenia Gravis |
4.2% |
| Neutropenia |
4.2% |
| Pituitary Tumour Benign |
4.2% |
| Psychotic Behaviour |
4.2% |
| Rabbit Syndrome |
4.2% |
| Renal Impairment |
4.2% |
| Restless Legs Syndrome |
4.2% |
| Sinus Bradycardia |
4.2% |
| Somnolence |
4.2% |
| Supraventricular Tachycardia |
4.2% |
| Tardive Dyskinesia |
4.2% |
| Thrombosis |
4.2% |
| Urinary Tract Infection |
4.2% |
|
| Secondary |
| Product Used For Unknown Indication |
36.6% |
| Schizophrenia, Paranoid Type |
8.9% |
| Schizophrenia |
7.3% |
| Psychotic Disorder |
6.5% |
| Completed Suicide |
5.7% |
| Schizoaffective Disorder |
4.9% |
| Anxiolytic Therapy |
3.3% |
| Obsessive-compulsive Disorder |
3.3% |
| Postpartum Depression |
3.3% |
| Affective Disorder |
2.4% |
| Cardiac Failure |
2.4% |
| Depression |
2.4% |
| Hypertension |
2.4% |
| Abnormal Behaviour |
1.6% |
| Antidepressant Therapy |
1.6% |
| Behavioural And Psychiatric Symptoms Of Dementia |
1.6% |
| Drug Use For Unknown Indication |
1.6% |
| Paranoid Psychosis |
1.6% |
| Personality Disorder |
1.6% |
| Cognitive Disorder |
0.8% |
|
| Toxicity To Various Agents |
21.9% |
| Tremor |
12.5% |
| Death |
6.3% |
| Exposure Via Ingestion |
6.3% |
| Tachyphrenia |
6.3% |
| Agitation |
3.1% |
| Completed Suicide |
3.1% |
| Disturbance In Attention |
3.1% |
| Hallucination, Visual |
3.1% |
| Hyperprolactinaemia |
3.1% |
| Neonatal Respiratory Distress Syndrome |
3.1% |
| Oculogyric Crisis |
3.1% |
| Oedema Peripheral |
3.1% |
| Overdose |
3.1% |
| Palpitations |
3.1% |
| Parkinsonism |
3.1% |
| Psychotic Disorder |
3.1% |
| Renal Failure Acute |
3.1% |
| Respiratory Arrest |
3.1% |
| Sepsis |
3.1% |
|
| Concomitant |
| Epilepsy |
13.3% |
| Schizophrenia |
10.0% |
| Bipolar Disorder |
6.7% |
| Breast Cancer |
6.7% |
| Obsessive-compulsive Disorder |
6.7% |
| Product Used For Unknown Indication |
6.7% |
| Tuberous Sclerosis |
6.7% |
| Alcoholism |
3.3% |
| Antidepressant Therapy |
3.3% |
| Atrial Fibrillation |
3.3% |
| Depression |
3.3% |
| Haematemesis |
3.3% |
| Mucopolysaccharidosis Ii |
3.3% |
| Multiple Sclerosis |
3.3% |
| Muscle Spasticity |
3.3% |
| Myelodysplastic Syndrome |
3.3% |
| Off Label Use |
3.3% |
| Prophylaxis |
3.3% |
| Schizoaffective Disorder |
3.3% |
| Schizophrenia, Paranoid Type |
3.3% |
|
| Toxicity To Various Agents |
12.5% |
| Dysarthria |
8.3% |
| Tic |
8.3% |
| Amnesia |
4.2% |
| Death |
4.2% |
| Drooling |
4.2% |
| Dysphagia |
4.2% |
| Haematochezia |
4.2% |
| Heart Rate Decreased |
4.2% |
| Hypersensitivity |
4.2% |
| Infusion Related Reaction |
4.2% |
| Laryngeal Oedema |
4.2% |
| Medication Error |
4.2% |
| Off Label Use |
4.2% |
| Platelet Disorder |
4.2% |
| Pleural Effusion |
4.2% |
| Product Substitution Issue |
4.2% |
| Psychomotor Hyperactivity |
4.2% |
| Pulmonary Embolism |
4.2% |
| Rash Erythematous |
4.2% |
|
